# Adaptimmune Therapeutics PLC: Form 8-K, filed Mar 30, 2017

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2017-03-30
- Accepted by EDGAR: Mar 30, 2017, 12:50 ET
- Period: 2017-03-27
- Accession: 0001104659-17-020261
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465917020261/a17-10157_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465917020261/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465917020261/a17-10157_18k.htm

Filed Mar 30, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-020261. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
